Evidence map›Paper›PMID 22675664›Full record

ReviewCold Spring Harbor perspectives in medicine2012

Generating β cells from stem cells-the story so far.

Matthias Hebrok

Abstract readReview
In one paragraph

Review in Cold Spring Harbor perspectives in medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Advanced therapy to cure diabetes: mission impossible is now possible?Frontiers in cell and developmental biology · 2024
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Herbal Medicines Targeting the ImprovedEvidence-based complementary and alternative medicine : eCAM · 2021
    Review
  7. The combined effect ofFEBS open bio · 2018
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Pancreatic stem cells remain unresolved.Stem cells and development · 2014
    Review
  16. Closing in on pancreatic beta cells.Nature biotechnology · 2014
    Article
  17. Article
  18. Functions and roles of proteins: diabetes as a paradigm.Progress in biophysics and molecular biology · 2014
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Matthias HebrokDiabetes Center, Department of Medicine, University of California, San Francisco, San Francisco, California, USA. mhebrok@diabetes.ucsf.edu

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite intensive research, a treatment for diabetic patients that completely restores normoglycemia for an indefinite period of time remains elusive. Although islet transplantation temporarily confers normoglycemia to patients, the lack of a renewable source of insulin-producing β cells hampers the use of this treatment option. Although significant hurdles remain, recent advances in stem cell biology indicate that generation of fully matured β cells from uncommitted progenitor cells, including human embryonic stem cells and induced pluripotent stem cells derived from somatic cell populations, is becoming an achievable goal.

Indexed as

Cell DifferentiationDiabetes MellitusEmbryonic Stem CellsHumansInduced Pluripotent Stem CellsInsulin-Secreting CellsIslets of Langerhans

Identifiers

PMID22675664
PMCPMC3367541

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.